ClinicalTrials.Veeva

Menu

Effectiveness of a Postal Intervention to Improve the Use of PPI

O

Osakidetza

Status

Completed

Conditions

Drug Overdose

Treatments

Other: Letter by post to patients

Study type

Interventional

Funder types

Other

Identifiers

NCT03840018
EVB-IBP-2017-01

Details and patient eligibility

About

It was a randomised intervention study, with before-and-after outcome measures and a control group, in patients who had an active long-term prescription for PPIs at high doses for at least 6 months.

Full description

The intervention consisted of sending patients an informative letter by post, in which their doctor invited them to seek an appointment for a medication review. Control group patients did not receive such a letter, and they were treated as usual (their doctors received a list of identifiers of patients on high doses).

The main outcome variable was the number of active prescriptions of each PPI dose (high dose/standard dose/treatment cessation) at 6 months after the intervention.

Enrollment

401 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients under the care of our organisation who in May 2017 had an active long-term prescription for PPIs at high doses for at least 6 months.

Exclusion criteria

  • Patients whose GPs declined to participate

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

401 participants in 2 patient groups

Control
No Intervention group
Description:
Sending doctors the lists of patients that meet the inclusion criteria to have their treatment reviewed
Letter by post to patients
Other group
Description:
Patients were sent a letter explaining the risks of using PPIs at long-term high doses and encouraging them to visit their doctor
Treatment:
Other: Letter by post to patients

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems